We have heard about the RNA vaccines and today MEDCRAM (118) will tell you about the Oxford/Astrazeneca Vaccine. This is the vaccine that the UK has purchased the most of. I think it is unlikely that it will be offered to people on immunosuppressive DMT, although it is replication deficient and so should not be able to cause an infection.
This week we had a nice email from Dr Seheult
It was great interest that I read your recent article entitled COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405500/
On behalf of Kyle Allred and the rest of the MedCram team, I wanted to thank you for acknowledging our work in your publication. We are honored and humbled that we could provide invaluable insights regarding pulmonary medicine and during the COVID-19 pandemic.
We also salute your invaluable work in the important area of vaccine response in those patients on medication such as rituximab, oblinutuzumab and ofatumumab.
Roger Seheult, M.D.”